Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

6825 ARTÍCULOS , VIENDO DEL 6526 AL 6540

Grey-Matter Structure Markers of Alzheimer's Disease, Alzheimer's Conversion, Functioning and Cognition: A Meta-Analysis Across 11 Cohorts

Couvy-Duchesne B, Frouin V, Bouteloup V, Koussis N, Sidorenko J, Jiang J, Wink AM, Lorenzini L, Barkhof F, Trollor JN, Mangin JF, Sachdev PS, Brodaty H, Lupton MK, Breakspear M, Colliot O, Visscher PM, Wray NR; Alzheimer's Disease Neuroimaging Initiative; Australian Imaging Biomarkers and Lifestyle flagship study of ageing; Alzheimer's Disease Repository Without Borders Investigators; MEMENTO cohort Study Group.

Hum Brain Mapp. 2025 Feb 1;46(2):e70089. doi: 10.1002/hbm.70089.

The effect of repetitive transcranial magnetic stimulation on immediate and long-term cognitive functions in Alzheimer's dementia and mild cognitive impairment: a meta-analysis

Wang B, Wang Y, Yang F, Han F, Li K, Sun K, Liang P.

J Neuroeng Rehabil. 2025 Dec 15;22(1):262. doi: 10.1186/s12984-025-01777-8.

Salience and frontoparietal network impairments across disease stages in dementia with Lewy bodies: A comparative functional MRI study with Alzheimer's disease

Gabriel V, Chabran E, Sourty M, Cretin B, Philippi N, Muller C, Anthony P, Demuynck C, Loureiro de Sousa P, Botzung A, Sanna L, Bousiges O, Blanc F.

J Alzheimers Dis. 2025 Dec;108(3):1398-1409. doi: 10.1177/13872877251386844. Epub 2025 Oct 17.

Cognitive training for Alzheimer's disease and other forms of dementia: Insights from a systematic review and Bayesian meta-analysis

Giaquinto F, Iaia M, Rizzi E, Macchitella L, Romano DL, Tosi G, Angelelli P.

J Alzheimers Dis. 2025 Jun;105(4):1252-1274. doi: 10.1177/13872877251334795. Epub 2025 May 13.

Structural and metabolic topological alterations associated with butylphthalide treatment in mild cognitive impairment: Data from a randomized, double-blind, placebo-controlled trial

Han X, Gong S, Gong J, Wang P, Li R, Chen R, Xu C, Sun W, Li S, Chen Y, Yang Y, Luan H, Wen B, Guo J, Lv S, Wei C.

Psychiatry Clin Neurosci. 2025 Jun;79(6):336-343. doi: 10.1111/pcn.13812. Epub 2025 Mar 31.

Incidence of Amyloid-Related Imaging Abnormalities in Phase III Clinical Trials of Anti-Amyloid-β Immunotherapy: An Updated Meta-Analysis

Jeong SY, Suh CH, Lim JS, Shim WH, Heo H, Choi Y, Kim HS, Kim SJ, Lee JH.

Neurology. 2025 Apr 22;104(8):e213483. doi: 10.1212/WNL.0000000000213483. Epub 2025 Mar 19.

Visuospatial impairment in dementia: a new index to improve the clinical diagnosis of Alzheimer's disease

Santagata F, Cappa SF, Presta R, Burgio C, Luppi C, Massaia M, Calvi E, D'Amelio P.

Aging Clin Exp Res. 2025 Apr 18;37(1):127. doi: 10.1007/s40520-025-03028-1.

A Retrospective Study of the Association between Low Vitamin B1 in the Blood and Cognitive Impairment in Patients with Alzheimer's Disease

Higaki Y, Kobayashi Y.

J Nutr Sci Vitaminol (Tokyo). 2025;71(5):421-426. doi: 10.3177/jnsv.71.421.

Hippocampal volume asymmetry in Alzheimer disease: A systematic review and meta-analysis

Pusparani Y, Lin CY, Jan YK, Lin FY, Liau BY, Alex JSR, Aparajeeta J, Chao WH, Lung CW.

Medicine (Baltimore). 2025 Mar 7;104(10):e41662. doi: 10.1097/MD.0000000000041662.

Diagnostic and prognostic multimodal prediction models in Alzheimer's disease: A scoping review

Xia X, Duffner LA, Bintener C, Bradshaw A, Lamirel D, Jönsson L.

J Alzheimers Dis. 2025 Nov;108(1_suppl):S209-S221. doi: 10.1177/13872877251351630. Epub 2025 Jun 26.

Effectiveness of Individual Cognitive Stimulation on Cognition in Mild Alzheimer's Disease: A Multicenter RCT

Justo-Henriques SI, Lemos R, Rahmatpour P, Silva RCG, Carvalho JO, Ribeiro O.

Psychogeriatrics. 2025 Nov;25(6):e70109. doi: 10.1111/psyg.70109.

High definition transcranial direct current stimulation as an intervention for cognitive deficits in Alzheimer's dementia: A randomized controlled trial

LoBue C, Chiang HS, Salter A, McClintock S, Nguyen TP, Logan R, Smernoff E, Pandya S, Hart J.

J Prev Alzheimers Dis. 2025 Feb;12(2):100023. doi: 10.1016/j.tjpad.2024.100023. Epub 2025 Jan 1.

The effect of tablet-based multimodal training on cognitive functioning in Alzheimer's disease: A randomized controlled trial

Zuschnegg J, Ropele S, Opriessnig P, Schmidt R, Russegger S, Fellner M, Leitner M, Spat S, Garcia ML, Strobl B, Ploder K, Pszeida M, Hofmarcher-Holzhacker MM, Stoegerer-Oberschmid E, Guttmann-Lattmanig A, Paletta L, Schüssler S, Koini M.

PLoS One. 2025 Aug 13;20(8):e0329931. doi: 10.1371/journal.pone.0329931. eCollection 2025.

Sativex (nabiximols) for the treatment of Agitation & Aggression in Alzheimer's dementia in UK nursing homes: a randomised, double-blind, placebo-controlled feasibility trial

Albertyn CP, Guu TW, Chu P, Creese B, Young A, Velayudhan L, Bhattacharyya S, Jafari H, Kaur S, Kandangwa P, Carter B, Aarsland D.

Age Ageing. 2025 May 31;54(6):afaf149. doi: 10.1093/ageing/afaf149.

Functional Imaging in Alzheimer's Disease: A Systematic Review and Meta-Analysis of ASL-MRI and FDG-PET

Radmard M, Gad M, Sheikhy A, Dagher R, Yedavalli V, Luna LP.

J Neuroimaging. 2025 Sep-Oct;35(5):e70080. doi: 10.1111/jon.70080.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias